Furthermore, peritumoral radiomics features can provide insights into the biological characteristics and pathological responses of HER2-positive breast cancer to preoperative targeted therapy by detecting biological information related to lymphocytic spatial structure, vascular invasion, and the immune response of surrounding breast tissue (39). Here, ERBB2 is linked to breast carcinoma.